Literature DB >> 2670849

Development and validation of a sensitive immunohistochemical oestrogen receptor assay for use on archival breast cancer tissue.

P Jackson1, J Teasdale, P N Cowen.   

Abstract

In a preliminary paper (Teasdale et al. 1987) comparing the oestrogen receptor (ER) content of breast cancers by the biochemical dextran coated charcoal (DCC) method and by two histochemical methods, peroxidase immunocytochemistry (ERICA) and immunogold-silver staining (IGSS), it was indicated that ERICA is more sensitive than DCC and that IGSS is as specific as ERICA but less sensitive. This paper describes the comparison of the above three assay methods with two other biochemical methods, iso-electric focusing (IEF) and an enzyme immuno-assay (EIA) on a larger number of cancers. All methods gave statistically comparable results except that IGSS remained less sensitive than the rest. Various modifications to IGSS showed that an immunogold streptavidin enhancement method (IG-SAM) produced sensitivity and specificity equal to that of ERICA. Since IGSS and its modifications are the only methods which can be used on archival paraffin-embedded cancers and IG-SAM gives results highly comparable to ERICA, retrospective studies can be performed on patients whose outcome and response to various treatments are known. Most recent studies have shown that ER positive results can be obtained from 10-year-old paraffin blocks.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670849     DOI: 10.1007/bf00490235

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  8 in total

1.  Surface membrane staining of immunoglobulins in paraffin sections of non-Hodgkin's lymphomas using immunogold-silver staining technique.

Authors:  C S Holgate; P Jackson; I Lauder; P N Cowen; C C Bird
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

2.  Immunogold-silver staining: new method of immunostaining with enhanced sensitivity.

Authors:  C S Holgate; P Jackson; P N Cowen; C C Bird
Journal:  J Histochem Cytochem       Date:  1983-07       Impact factor: 2.479

3.  Steroid-hormone receptors in breast cancer.

Authors:  J L Wittliff
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

4.  The prognostic role of progesterone receptors in human breast cancer.

Authors:  W L McGuire; G M Clark
Journal:  Semin Oncol       Date:  1983-12       Impact factor: 4.929

5.  Fixation, processing, and immunochemical reagent effects on preservation of T-lymphocyte surface membrane antigens in paraffin-embedded tissue.

Authors:  K Pollard; D Lunny; C S Holgate; P Jackson; C C Bird
Journal:  J Histochem Cytochem       Date:  1987-11       Impact factor: 2.479

6.  Identification of oestrogen receptors in cells of paraffin-processed breast cancers by IGSS.

Authors:  J Teasdale; P Jackson; C S Holgate; P N Cowen
Journal:  Histochemistry       Date:  1987

7.  Oestrogen receptor assay of cryostat sections of human breast carcinomas with simultaneous quantitative histology.

Authors:  J C Underwood; V J Dangerfield; M A Parsons
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

8.  Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.

Authors:  M R Williams; J H Todd; I O Ellis; C S Dowle; J L Haybittle; C W Elston; R I Nicholson; K Griffiths; R W Blamey
Journal:  Br J Cancer       Date:  1987-01       Impact factor: 7.640

  8 in total
  3 in total

1.  Ultrastructural localisation of oestrogen receptor in breast cancer cell nuclei.

Authors:  P J Walsh; J Teasdale; P N Cowen
Journal:  Histochemistry       Date:  1990

2.  Classical oestrogen receptor is not detectable in pancreatic adenocarcinoma.

Authors:  O M Taylor; J Teasdale; P N Cowen; M J McMahon; E A Benson
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

3.  Predicting aggressive outcome in T1N0M0 breast cancer.

Authors:  P Kronqvist; T Kuopio; M Nykänen; H Helenius; J Anttinen; P Klemi
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.